共 60 条
- [31] Mendez, Naus, Elisevich, Flumerfelt, Normalization of striatal proenkephalin and preprotachykinin mRNA expression by fetal substantia nigra grafts, Expl Neurol., 119, pp. 1-10, (1993)
- [32] Mitchell, Clarke, Boyce, Robertson, Pegg, Sambrook, Crossman, Neuronal mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neuroscience, 32, pp. 213-226, (1989)
- [33] Morelli, Pontieri, Linfante, Orzi, DiChiara, Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats, effect of sensitization (priming) with a dopaminergic agonist, Synapse, 13, pp. 264-269, (1993)
- [34] Mouradian, Heuser, Baronti, Chase, Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease, Ann. Neurol., 27, pp. 18-23, (1990)
- [35] Mulder, Wardeh, Hogenboom, Frankhuyzen, Kappa and delta opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release, Nature, 308, pp. 278-280, (1984)
- [36] Parent, Lavoie, The heterogeneity of the mesostriatal dopaminergic system as revealed in normal and parkinsonian monkeys, Advances in Neurology, 60, pp. 25-33, (1993)
- [37] Paxinos, Watson, The Rat Brain in Stereotaxic Coordinates, (1986)
- [38] Pehek, Crock, Yamamoto, Selective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions, Synapse, 10, pp. 317-325, (1992)
- [39] Pickel, Chan, Sesack, Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra, Brain Res., 602, pp. 275-289, (1993)
- [40] Reiner, Anderson, The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings, Brain Res. Rev., 15, pp. 251-265, (1990)